Group 1: Financial Performance - In the first half of 2025, the company achieved revenue of 914 million CNY, remaining stable compared to the same period last year, with a net profit of 154 million CNY, representing a year-on-year growth of approximately 23% [2] - Domestic market sales revenue was 356 million CNY, a year-on-year decrease of about 13%, primarily due to delays in procurement plans from medical institutions influenced by domestic economic conditions and industry policy adjustments [2] - The second quarter revenue reached 493 million CNY, a quarter-on-quarter increase of around 17%, with domestic market contributing 191 million CNY and overseas market contributing 303 million CNY, reflecting quarter-on-quarter growth of 15% and 19% respectively [3] Group 2: Business Segments - The monitoring business generated revenue of 268 million CNY in the first half of 2025, with Q1 at 117 million CNY and Q2 at 151 million CNY, showing a quarter-on-quarter growth of approximately 29% in Q2 [4] - The ultrasound business achieved revenue of 149 million CNY, with Q1 at 68 million CNY and Q2 at 81 million CNY, reflecting a quarter-on-quarter growth of about 19% in Q2 [4] - The overseas market generated revenue of 557 million CNY, a year-on-year increase of 8.33%, with exports accounting for around 60% of total sales [7] Group 3: Inventory and Supply Chain - In 2023, the company faced inventory levels exceeding 400 million CNY due to public health events and chip supply issues, but by mid-2025, inventory was reduced to approximately 330 million CNY, indicating significant destocking effects [6] Group 4: Future Outlook - For 2025, the company aims to maintain stable domestic business performance while striving for year-on-year growth, with expectations of a 25% decline in domestic business for 2024 being mitigated by improved performance in Q1 and Q2 of 2025 [5] - The company plans to enhance overseas market expansion and localization efforts, leveraging over 20 years of customer resource accumulation to drive growth in foreign sales [17] - The introduction of new products and the application of AI technology are anticipated to be key drivers for future revenue growth [17]